Class 2 MHRA Medicines Recall – Aripiprazole 1mg/ml oral solution (Dr. Reddy’s Laboratories (UK) Ltd)

Class 2 MHRA Medicines Recall – Aripiprazole 1mg/ml oral solution (Dr. Reddy’s Laboratories (UK) Ltd)

September 12, 2019

Drug alert number: EL (19) A/21
Date issued: 12 September 2019 

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 pharmacy level medicines recall, to be actioned within 48 hours, for certain batches of Aripiprazole 1mg/ml oral solution.

Dr. Reddy’s Laboratories (UK) Ltd is recalling the above batch due to the potential for small particles of Aripiprazole active material to be present which may affect the efficacy of the product. A product complaint has been received by the company from the UK market, relating to the formation of a precipitate in a bottle of product.

Aripiprazole 1mg/ml oral solution PL 08553/0582

Batch Number Expiry Date Pack Size First Distributed
 050618 05/2020   150ml  13 July 2018

Community pharmacy teams should stop supplying the above products/batches immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

To view the alert please visit the GOV.UK website.

Company contacts for further information

For stock control enquiries please contact Dr. Reddy’s Laboratories (UK) Ltd Customer Services Team on +44 (0)1482 389858, email: customerserviceuk@drreddys.com (or main switchboard +44 (0)1482 860228).

For medical information enquiries please contact Dr. Reddy’s Laboratories (UK) Ltd Medical Information Department on +44 (0)1748 828873 and DrReddys@professionalinformation.co.uk.



Posted in:


More Latest News >

CPCS webinar now on-demand

Community pharmacy contractors can now access an online recording of our webinar about the new NHS Community Pharmacist Consultation Service...